Ma et al.233 examined the expression levels of CD163 in patients with CRC versus healthy individuals, screened for four related genes and finally revealed that CD163 was differentially expressed in CRC tissues and was a poor prognostic factor. Here, CD163 is linked to colorectal carcinoma.